{"id":"https://openalex.org/W7224656558","doi":"https://doi.org/10.1002/npr2.70175","title":"Distinct Associations of Age and CYP2D6 Genotype With Parent Venlafaxine Exposure and O\u2010Demethylation in Japanese Psychiatric Patients","display_name":"Distinct Associations of Age and CYP2D6 Genotype With Parent Venlafaxine Exposure and O\u2010Demethylation in Japanese Psychiatric Patients","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224656558","doi":"https://doi.org/10.1002/npr2.70175","pmid":"https://pubmed.ncbi.nlm.nih.gov/42956830","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13719267"},"language":"en","primary_location":{"id":"doi:10.1002/npr2.70175","doi":"https://doi.org/10.1002/npr2.70175","is_oa":true,"landing_page_url":"https://doi.org/10.1002/npr2.70175","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/npr2.70175","source":{"id":"https://openalex.org/S4210189692","display_name":"Neuropsychopharmacology Reports","issn_l":"2574-173X","issn":["2574-173X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/npr2.70175","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037766840","display_name":"Yugo Ishihara","orcid":"https://orcid.org/0009-0004-5572-4724","observed_orcids":["https://orcid.org/0009-0004-5572-4724"]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yugo Ishihara","raw_affiliation_strings":["Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan"],"raw_orcid":"https://orcid.org/0009-0004-5572-4724","affiliations":[{"raw_affiliation_string":"Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan","institution_ids":["https://openalex.org/I78274823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103797151","display_name":"Taro Sasaki","orcid":"https://orcid.org/0000-0003-3289-4080","observed_orcids":["https://orcid.org/0000-0003-3289-4080"]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Taro Sasaki","raw_affiliation_strings":["Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan","institution_ids":["https://openalex.org/I78274823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113803545","display_name":"Tomohiro Asahi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomohiro Asahi","raw_affiliation_strings":["Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan","institution_ids":["https://openalex.org/I78274823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5146539786","display_name":"Yujin Ono","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yujin Ono","raw_affiliation_strings":["Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan","institution_ids":["https://openalex.org/I78274823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033813261","display_name":"Tomomi Sugisaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomomi Sugisaki","raw_affiliation_strings":["Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan","institution_ids":["https://openalex.org/I78274823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148985571","display_name":"Rina Hiramatsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Rina Hiramatsu","raw_affiliation_strings":["Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan","institution_ids":["https://openalex.org/I78274823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085039020","display_name":"Yasushi Kawamata","orcid":"https://orcid.org/0000-0002-9879-9492","observed_orcids":["https://orcid.org/0000-0002-9879-9492"]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasushi Kawamata","raw_affiliation_strings":["Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan"],"raw_orcid":"https://orcid.org/0000-0002-9879-9492","affiliations":[{"raw_affiliation_string":"Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan","institution_ids":["https://openalex.org/I78274823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055511638","display_name":"Norio Sugawara","orcid":"https://orcid.org/0000-0001-7058-664X","observed_orcids":["https://orcid.org/0000-0001-7058-664X"]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Norio Sugawara","raw_affiliation_strings":["Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan"],"raw_orcid":"https://orcid.org/0000-0001-7058-664X","affiliations":[{"raw_affiliation_string":"Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan","institution_ids":["https://openalex.org/I78274823"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088581964","display_name":"Norio Yasui\u2010Furukori","orcid":"https://orcid.org/0000-0002-4414-3770","observed_orcids":["https://orcid.org/0000-0002-4414-3770","https://orcid.org/0000-0003-2710-5964"]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Norio Yasui\u2010Furukori","raw_affiliation_strings":["Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan"],"raw_orcid":"https://orcid.org/0000-0002-4414-3770","affiliations":[{"raw_affiliation_string":"Department of Psychiatry Dokkyo Medical University School of Medicine  Tochigi Japan","institution_ids":["https://openalex.org/I78274823"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5088581964"],"corresponding_institution_ids":["https://openalex.org/I78274823"],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":{"value":2500,"currency":"USD","value_usd":2500},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82016438,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"46","issue":"4","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":1.0},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.8420000076293945},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.531000018119812},{"id":"https://openalex.org/keywords/o-demethylation","display_name":"O-demethylation","score":0.8629999756813049},{"id":"https://openalex.org/keywords/drug-exposure","display_name":"drug exposure","score":0.6320000290870667},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.6790000200271606},{"id":"https://openalex.org/keywords/geriatric-pharmacology","display_name":"geriatric pharmacology","score":0.6679999828338623},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.7689999938011169},{"id":"https://openalex.org/keywords/psychiatric-patients","display_name":"psychiatric patients","score":0.7480000257492065},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.5669999718666077}],"concepts":[{"id":"https://openalex.org/C33664856","wikidata":"https://www.wikidata.org/wiki/Q3271142","display_name":"CYP2D6","level":4,"score":0.857699990272522},{"id":"https://openalex.org/C9583187","wikidata":"https://www.wikidata.org/wiki/Q7919510","display_name":"Ven","level":2,"score":0.7745000123977661},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.708299994468689},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5845000147819519},{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.5709999799728394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5597000122070312},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.47380000352859497},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.43950000405311584},{"id":"https://openalex.org/C149737253","wikidata":"https://www.wikidata.org/wiki/Q3240252","display_name":"Polymorphism (computer science)","level":4,"score":0.3255999982357025},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.3100000023841858},{"id":"https://openalex.org/C175239580","wikidata":"https://www.wikidata.org/wiki/Q656595","display_name":"Genotype frequency","level":5,"score":0.30469998717308044},{"id":"https://openalex.org/C2777767895","wikidata":"https://www.wikidata.org/wiki/Q4691924","display_name":"Age of onset","level":3,"score":0.3043000102043152},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.3005000054836273},{"id":"https://openalex.org/C48921125","wikidata":"https://www.wikidata.org/wiki/Q10861030","display_name":"Linear regression","level":2,"score":0.28760001063346863},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.28760001063346863},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.27889999747276306},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2727000117301941},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.26330000162124634},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.2587999999523163},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2547000050544739},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.2524999976158142}],"mesh":[{"descriptor_ui":"D000069468","descriptor_name":"Desvenlafaxine Succinate","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000095225","descriptor_name":"East Asian People","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019389","descriptor_name":"Cytochrome P-450 CYP2D6","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/npr2.70175","doi":"https://doi.org/10.1002/npr2.70175","is_oa":true,"landing_page_url":"https://doi.org/10.1002/npr2.70175","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/npr2.70175","source":{"id":"https://openalex.org/S4210189692","display_name":"Neuropsychopharmacology Reports","issn_l":"2574-173X","issn":["2574-173X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13719267","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13719267/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13719267/pdf/NPR2-46-e70175.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacol Rep","raw_type":"Text"},{"id":"pmid:42956830","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42956830","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology reports","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/npr2.70175","doi":"https://doi.org/10.1002/npr2.70175","is_oa":true,"landing_page_url":"https://doi.org/10.1002/npr2.70175","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/npr2.70175","source":{"id":"https://openalex.org/S4210189692","display_name":"Neuropsychopharmacology Reports","issn_l":"2574-173X","issn":["2574-173X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320311405","display_name":"Japan Agency for Medical Research and Development","ror":"https://ror.org/004rtk039"},{"id":"https://openalex.org/F4320321607","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38"},{"id":"https://openalex.org/F4320321945","display_name":"Ministry of Health, Labour and Welfare","ror":"https://ror.org/03mwa7s65"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224656558.pdf","grobid_xml":"https://content.openalex.org/works/W7224656558.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W1785435186","https://openalex.org/W1970846917","https://openalex.org/W2079138510","https://openalex.org/W2606661844","https://openalex.org/W2895853627","https://openalex.org/W3112570172","https://openalex.org/W3122443703","https://openalex.org/W4362735831","https://openalex.org/W4391322849"],"related_works":["https://openalex.org/W3012358180","https://openalex.org/W3112570172","https://openalex.org/W2089348163","https://openalex.org/W2098768607","https://openalex.org/W2491427816","https://openalex.org/W7125698512","https://openalex.org/W1488321941","https://openalex.org/W3009539525","https://openalex.org/W2002050650","https://openalex.org/W2034717120"],"abstract_inverted_index":{"ABSTRACT":[0],"Background":[1],"Venlafaxine":[2],"(VEN)":[3],"is":[4],"converted":[5],"to":[6,212,217,262],"O\u2010desmethylvenlafaxine":[7],"(ODV)":[8],"mainly":[9],"through":[10],"CYP2D6\u2010mediated":[11],"O\u2010demethylation.":[12],"However,":[13],"age\u2010related":[14],"clinical":[15],"factors":[16,260],"may":[17,254],"also":[18],"influence":[19],"VEN":[20,56,72,220,263],"exposure":[21,37,250],"in":[22],"routine":[23],"practice.":[24],"We":[25],"examined":[26],"whether":[27],"age":[28,102,155,235],"and":[29,38,57,60,79,84,90,103,130,251,258],"CYP2D6":[30,61,104,162,182,223],"genotype":[31,62,224],"show":[32],"different":[33],"associations":[34],"with":[35,53,121,181,199],"parent\u2010drug":[36],"metabolic":[39,229],"conversion.":[40],"Methods":[41],"This":[42],"retrospective":[43],"therapeutic":[44],"drug":[45],"monitoring":[46],"analysis":[47],"included":[48],"78":[49],"Japanese":[50],"psychiatric":[51],"patients":[52,110,132,138],"available":[54],"plasma":[55],"ODV":[58],"concentrations":[59],"data.":[63],"Two":[64],"prespecified":[65],"outcomes":[66,95,253],"were":[67,86,96,112,203],"analyzed":[68,97],"without":[69],"body\u2010weight":[70],"correction:":[71],"concentration":[73],"divided":[74],"by":[75],"daily":[76],"dose":[77],"(VEN/dose)":[78],"the":[80,150,175,227],"ODV/VEN":[81,176,228],"ratio.":[82,230],"CYP2D6*10":[83],"*5":[85],"coded":[87],"as":[88],"reduced\u2010":[89],"no\u2010function":[91],"alleles,":[92],"respectively.":[93],"Log\u2010transformed":[94],"using":[98],"regression":[99,148],"models":[100],"including":[101],"reduced/no\u2010function":[105],"allele":[106,163,183],"count.":[107],"Results":[108],"Nineteen":[109],"(24.4%)":[111],"aged":[113],"65":[114],"years":[115],"or":[116],"older.":[117],"Age":[118,210],"was":[119,156,178,247],"correlated":[120],"VEN/dose":[122,135,166],"(Spearman":[123],"rho":[124],"=":[125,128,145,187,195],"0.295,":[126],"p":[127,144,189],"0.0086),":[129],"older":[131],"had":[133],"higher":[134],"than":[136,159],"younger":[137],"(median,":[139],"0.522":[140],"vs.":[141,172],"0.192":[142],"[ng/mL]/[mg/day],":[143],"0.0127).":[146],"In":[147],"analysis,":[149],"incremental":[151,192],"R":[152,168,193],"2":[153,169,194],"for":[154,161,165,206],"numerically":[157],"larger":[158],"that":[160],"count":[164,184],"(incremental":[167],",":[170],"0.058":[171],"0.026).":[173],"Conversely,":[174],"ratio":[177],"strongly":[179],"associated":[180],"(standardized":[185],"beta":[186],"\u22120.391,":[188],"<":[190],"0.001;":[191],"0.145)":[196],"but":[197],"not":[198,204],"age.":[200],"Age\u2010by\u2010genotype":[201],"interactions":[202],"significant":[205],"either":[207],"outcome.":[208],"Conclusions":[209],"appeared":[211],"be":[213,237],"more":[214],"closely":[215],"related":[216],"dose\u2010corrected":[218],"parent":[219],"exposure,":[221],"whereas":[222],"predominantly":[225],"determined":[226],"The":[231],"relative":[232],"contribution":[233],"of":[234,244],"should":[236],"interpreted":[238],"descriptively":[239],"because":[240],"no":[241],"formal":[242],"comparison":[243],"effect":[245],"sizes":[246],"performed.":[248],"Separating":[249],"metabolic\u2010ratio":[252],"clarify":[255],"how":[256],"geriatric":[257],"pharmacogenetic":[259],"contribute":[261],"disposition.":[264]},"counts_by_year":[],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2026-10-30T00:00:00"}
